- Home
- NMRA vs TOUR Comparison
NMRA vs TOUR Comparison
Compare NMRA & TOUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- TOUR
- Stock Information
- Founded
- NMRA 2019
- TOUR 2006
- Country
- NMRA United States
- TOUR China
- Employees
- NMRA N/A
- TOUR N/A
- Industry
- NMRA
- TOUR Transportation Services
- Sector
- NMRA
- TOUR Consumer Discretionary
- Exchange
- NMRA Nasdaq
- TOUR Nasdaq
- Market Cap
- NMRA 112.8M
- TOUR 101.0M
- IPO Year
- NMRA 2023
- TOUR 2014
- Fundamental
- Price
- NMRA $0.73
- TOUR $0.92
- Analyst Decision
- NMRA Buy
- TOUR
- Analyst Count
- NMRA 8
- TOUR 0
- Target Price
- NMRA $9.29
- TOUR N/A
- AVG Volume (30 Days)
- NMRA 846.2K
- TOUR 122.4K
- Earning Date
- NMRA 05-12-2025
- TOUR 06-12-2025
- Dividend Yield
- NMRA N/A
- TOUR 3.96%
- EPS Growth
- NMRA N/A
- TOUR N/A
- EPS
- NMRA N/A
- TOUR 0.09
- Revenue
- NMRA N/A
- TOUR $70,367,853.00
- Revenue This Year
- NMRA N/A
- TOUR $16.99
- Revenue Next Year
- NMRA N/A
- TOUR $13.23
- P/E Ratio
- NMRA N/A
- TOUR $10.54
- Revenue Growth
- NMRA N/A
- TOUR 16.40
- 52 Week Low
- NMRA $0.61
- TOUR $0.71
- 52 Week High
- NMRA $17.19
- TOUR $1.76
- Technical
- Relative Strength Index (RSI)
- NMRA 45.93
- TOUR 46.11
- Support Level
- NMRA $0.66
- TOUR $0.88
- Resistance Level
- NMRA $0.73
- TOUR $0.94
- Average True Range (ATR)
- NMRA 0.06
- TOUR 0.03
- MACD
- NMRA 0.01
- TOUR -0.00
- Stochastic Oscillator
- NMRA 59.70
- TOUR 35.71
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About TOUR Tuniu Corporation
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.